WHO declared Monkeypox a PHEIC for the second time
The WHO jusy declared the monkeypox a Public Health Emergency of International Concern. The last time the WHO declared the monkeypox a PHEIC is was really fake. I will start with some reminders from the 2022 declaration and then move on to more current reporting.
Monkeypox simulation March 2021 Munich Security Conference. July 23, 2022, the Director General of WHO declared a PHEIC Monkeyox against a majority vote of the International Health Regulations (IHR) Emergency Committee (9-6).
Reported in 2022: Monkeypox was first identified in 1958, but there’s never been a global Monkeypox outbreak outside of Africa until now—in the exact week of the exact month predicted by the biosecurity folks in their pandemic simulation. Elite media outlets around the world are on red alert over the world’s first-ever global outbreak of Monkeypox in mid-May 2022—just one year after an international biosecurity conference in Munich held a simulation of a “global pandemic involving an unusual strain of Monkeypox” beginning in mid-May 2022.
In 2022 Expose-News reported the monkeypox outbreak to most likely be a GoF virus due to the 2022 outbreak picking up variants in a short span of time it would normally take the virus at least 50 years to do. “By chance, what the scientists discovered is that the alleged circulating monkeypox virus contains a ’30-T long sequence in the centre of the monkeypox genome, between the DNA-dependent RNA ad the cowpox A-type inclusion protein. / We allegedly have a circulating monkeypox virus in several first-world countries at the same time for the first time in history, and this alleged virus has over 50 mutations that have occurred in the space of 4 years instead of the 50 years it should have taken. And now we know it contains something that just shouldn’t be there.”
In 2022 there was a monkeypox scenario made beforehand:
"The waning population immunity associated with discontinuation of smallpox vaccination has established the landscape for the resurgence of monkeypox." "Monkeypox was not reported outside Africa until 2003."
Current status of Monkeypox according to Our World in Data:
Squak media reported the following on the PHEIC monkeypox 2024: “escalating number of monkeypox cases worldwide, with more than 60,000 confirmed cases reported across 55 countries as of early August 2024. /—/ Monkeypox, a viral zoonotic disease related to smallpox, has typically been limited to remote areas of Central and West Africa. However, since early 2022, the virus has surfaced in regions where it had yet to be documented, including Europe, the Americas, and Asia. The current outbreak is not just large but unparalleled in its size and geographic spread, underscoring the gravity of the situation.”
Thailand Medical News on June 26, 2024: Unconfirmed reports emerging that new strain of Mpox(Monkeypox) has enhanced airborne properties. Can spread effectively without sexual contact! Are we to assume that this occurred as a result of natural evolution or something else!!! Seriously, can DARPA stop all its programs!
World Council for Health on the monkeypox in 2022:
What is monkeypox?
Monkeypox is a disease caused by the monkeypox virus. It is in the same family of viruses as the virus that causes smallpox. Monkeypox is rare, milder than smallpox, and is rarely fatal.
The virus was first discovered in an outbreak among research monkeys in 1958. In 1970, the first human case was recorded in the Democratic Republic of the Congo. Cases are typically found in central and west Africa or in those having recently traveled to the area.
What are the symptoms?
Typical symptoms include fever, headache, swelling, back pain, and aching muscles. Following the fever, a rash can appear, often first on the face before spreading to other parts of the body. The rash and lesions can be painful and itchy, going through multiple stages before forming a scab that eventually falls off.
Monkeypox infection typically clears up on its own within 14 to 21 days.
How is monkeypox spread?
Monkeypox is spread through close contact via broken skin, the respiratory tract, the eyes, the mouth, and bodily fluids. Transmission via respiratory particles results from prolonged face-to-face contact.
According to new research published July 21 in the New England Journal of Medicine, “Transmission was suspected to have occurred through sexual activity in 95%” of 528 infections observed between April 27 and June 24. It is recommended to abstain from sexual activity if infected.
How is monkeypox treated?
Monkey pox is a self-limiting disease. Treatment may include vitamin D, zinc, N-acetyl cysteine (NAC), selenium, Sarracenia purpurea extract, and nitizoxamide.
Patientmakt June 27, 2024: It is being reported about Congo an airborne monkeypox variant clade B1 is spreading in schools, workplaces and from mother to child in Congo. The clade B1 has a 5 % fatality rate for adults and a 10 % fatality rate for children.
Airborne Monkeypox with lethality rate 5 - 10 % in Congo
In Congressional hearings Anthony Fauci hid info on GoF (Gain-of-Function) monkeypox virus with 15 % fatality rate. The Childrens Health Defense:
Mpox caused a public health emergency in the U.S. from August 2022 to February 2023. It is endemic in Africa. The more deadly clade circulates in Central Africa (clade I) while the more transmissible clade circulates in West Africa (clade II).
Mpox has infected more than 20,000 people and caused more than 1,000 deaths in the Democratic Republic of Congo, where clade I predominates, according to the Centers for Disease Control and Prevention — though some experts believe that is an undercount of true cases. A strain of the clade II virus drove the U.S. outbreak.
On June 8, 2024 The Defender reported (excerpt):
The World Health Organization (WHO) today triggered the process to grant Emergency Use Listing to two monkeypox vaccines.
WHO Director-General Tedros Adhanom Ghebreyesus told the media the listing will accelerate vaccine access in lower-income countries that have not yet approved the drugs.
“Emergency Use Listing also enables partners including Gavi and UNICEF to procure vaccines for distribution,” Tedros said. He also said he would convene an expert group to determine if the spread of monkeypox — renamed mpox — in Africa should be declared a global emergency.
Dr. Meryl Nass, an internist and biological warfare expert, told The Defender that in Africa, the disease has reportedly been more deadly. The numbers, she said, are difficult to confirm.
Tedros did not name the vaccines that will receive Emergency Use Listing, but Nass said there are two monkeypox vaccines: Jynneos and ACAM2000.
Both were originally approved to fight smallpox. Jynneos was licensed for monkeypox in the U.S. in 2019 — when no outbreak was ongoing. ACAM2000 has been “made available for use against mpox in the current outbreak [2022] under an Expanded Access Investigational New Drug (EA-IND) protocol.”
The drugs cause myocarditis, pericarditis and other serious side effects at high rates, Nass said, as the labels for both drugs indicate.
Nass also said there are serious questions about the efficacy of the vaccines. According to the labels, the efficacy rates are inferred based on immunogenicity studies, which study antibody responses, rather than testing whether a vaccine protects against disease.